Search Results 1881-1890 of 21502 for platelets

1. Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma - Mayo Clinic

   Platelet (Plt) 100,000/mm^3. Renal. Serum Creatinine ≤ 1.5 x ULN. Hepatic. Alkaline Phosphatase (Alk Phos) ≤ 1.5 x upper limit of normal (ULN);; Total and ...

2. Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Metastatic Colorectal Cancer (OBERTO) - Mayo Clinic

   Platelets ≥100 × 109/L, hemoglobin ≥5.6 mmol/L (corresponding to 9 g/dL). Serum bilirubin ≤1.5 × upper limit of normal (ULN) set by the site. Alanine ...

3. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

   Platelet count ≥75,000/μL;; Hemoglobin ≥8.0 g/dL;; Serum total bilirubin ≤1.5 × upper limit of normal (ULN) or ≤3 × ULN for subjects with Gilbert's ...

4. Individualized Temozolomide in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

   Platelet count ≥ 100,000/mcl; Hemoglobin ≥ 9gm/mcl; Creatinine ≤ 2.5 x upper limit of normal (ULN); Aspartate aminotransferase (AST) ≤ 3 x ULN; Negative ...

5. Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions - Mayo Clinic

   Platelet count >= 100,000/mm^3; Hemoglobin >= 9.0 g/dL; Total bilirubin =< 1.5 x upper limit of normal (ULN), unless due to Gilbert's syndrome; Aspartate ...

6. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

   Platelet count >= 100,000/mm^3; Hemoglobin >= 9.0 g/dl; Total bilirubin =< 2.0 mg/dl; Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3.0 x ...

7. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation - Mayo Clinic

   is not on birth control. 4. The participant is being treated with chronic aspirin, another anti-platelet agent, or chronic NSAIDS outside of current medical ...

8. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... platelet count ≤ 100,000/mm³) not due to autoimmune disease; Symptomatic or progressive lymphadenopathy, splenomegaly, or hepatomegaly; Progressive ...

9. Safety And Efficacy Study Of The Medtronic CoreValve® System In The Treatment Of Severe, Symptomatic Aortic Stenosis In Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). - Mayo Clinic

   Blood dyscrasias as defined: leukopenia (WBC <1000mm3), thrombocytopenia (platelet count <50,000 cells/mm3), history of bleeding diathesis or coagulopathy; ...

10. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Platelets ˃75,000/mm³; Creatinine clearance ≥ 50 mL/min, calculated with the use of 24-hour creatinine clearance or by Cockcroft-Gault formula; Total ...